Safety of rosuvastatinSHEPHERD, James; HUNNINGHAKE, Donald B; STEIN, Evan A et al.The American journal of cardiology. 2004, Vol 94, Num 7, pp 882-888, issn 0002-9149, 7 p.Article

Efficacy of Rosuvastatin (5 mg and 10 mg) Twice a Week in Patients Intolerant to Daily StatinsGADARLA, Mamatha; KEARNS, Amy K; THOMPSON, Paul D et al.The American journal of cardiology. 2008, Vol 101, Num 12, pp 1747-1748, issn 0002-9149, 2 p.Article

Once-a-Week Rosuvastatin (2.5 to 20 mg) in Patients With a Previous Statin IntoleranceRUISINGER, Janelle F; BACKES, James M; GIBSON, Cheryl A et al.The American journal of cardiology. 2009, Vol 103, Num 3, pp 393-394, issn 0002-9149, 2 p.Article

Effects of Maximal Doses of Atorvastatin Versus Rosuvastatin on Small Dense Low-Density Lipoprotein Cholesterol LevelsAI, Masumi; OTOKOZAWA, Seiko; ASZTALOS, Bela F et al.The American journal of cardiology. 2008, Vol 101, Num 3, pp 315-318, issn 0002-9149, 4 p.Article

Monday, wednesday, and friday dosing of Rosuvastatin in patients previously intolerant to statin therapyMACKIE, Benjamin D; SATIJA, Sameer; NELL, Christine et al.The American journal of cardiology. 2007, Vol 99, Num 2, issn 0002-9149, 291Article

Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: Rationale and design of the JUPITER trialRIDKER, Paul M.Circulation (New York, N.Y.). 2003, Vol 108, Num 19, pp 2292-2297, issn 0009-7322, 6 p.Article

Effects of Maximal Atorvastatin and Rosuvastatin Treatment on Markers of Glucose Homeostasis and InflammationTHONGTANG, Nuntakorn; AI, Masumi; OTOKOZAWA, Seiko et al.The American journal of cardiology. 2011, Vol 107, Num 3, pp 387-392, issn 0002-9149, 6 p.Article

Coenzyme Q10, Rosuvastatin, and Clinical Outcomes in Heart Failure: A Pre-Specified Substudy of CORONA (Controlled Rosuvastatin Multinational Study in Heart Failure)MCMURRAY, John J. V; DUNSELMAN, Peter; BÖHM, Michael et al.Journal of the American College of Cardiology. 2010, Vol 56, Num 15, pp 1196-1204, issn 0735-1097, 9 p.Article

CISSI-HF : effet des AGPI et de la rosuvastatine chez des patients avec insuffisance cardiaque symptomatique (NYHA II à IV) [1, 2]MADIOU, J. P.La Lettre du cardiologue. 2009, Num 423, pp 17-18, issn 0761-5035, 2 p., SUPConference Paper

Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patientsMIAO HU; LUI, Sandra S. H; LI, Edmund K et al.Pharmacogenetics and genomics (Print). 2010, Vol 20, Num 10, pp 634-637, issn 1744-6872, 4 p.Article

Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy VolunteersKISER, Jennifer J; GERBER, John G; PREDHOMME, Julie A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 570-578, issn 1525-4135, 9 p.Article

Effect of short-term Rosuvastatin treatment on estimated glomerular filtration rateVIDT, Donald G; HARRIS, Susan; MCTAGGART, Fergus et al.The American journal of cardiology. 2006, Vol 97, Num 11, pp 1602-1606, issn 0002-9149, 5 p.Article

Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2-Dependent MechanismLIUNI, Andrew; LUCA, Mary Clare; GORI, Tommaso et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 10, pp 1002-1006, issn 0735-1097, 5 p.Article

Safety and Efficacy of Achieving Very Low Low-Density Lipoprotein Cholesterol Levels With Rosuvastatin 40 mg Daily (from the ASTEROID Study)WIVIOTT, Stephen D; MOHANAVELU, Satishkumar; RAICHLEN, Joel S et al.The American journal of cardiology. 2009, Vol 104, Num 1, pp 29-35, issn 0002-9149, 7 p.Article

Determination of rosuvastatin in the presence of its degradation products by a stability-indicating LC methodMEHTA, Tushar N; PATEL, Atul K; KULKARNI, Gopal M et al.Journal of AOAC International. 2005, Vol 88, Num 4, pp 1142-1147, issn 1060-3271, 6 p.Article

Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) studySCHUSTER, Herbert; BARTER, Philip J; STENDER, Steen et al.The American heart journal. 2004, Vol 147, Num 4, pp 705-712, issn 0002-8703, 8 p.Article

Development and Validation of a Liquid Chromatography/ Mass Spectrometry Method for the Simultaneous Quantitation of Rosuvastatin and Ezetimibe in Human PlasmaVARGHESE, Susheel John; THENGUNGAL KOCHUPAPPY RAVI.Journal of AOAC International. 2013, Vol 96, Num 2, pp 307-312, issn 1060-3271, 6 p.Article

Comparison of the effects of high doses of Rosuvastatin versus Atorvastatin on the subpopulations of high-density lipoproteinsASZTALOS, Bela F; LE MAULF, Florence; DALLAL, Gerald E et al.The American journal of cardiology. 2007, Vol 99, Num 5, pp 681-685, issn 0002-9149, 5 p.Article

Effects of once weekly Rosuvastatin among patients with a prior statin intoleranceBACKES, James M; MORIARTY, Patrick M; RUISINGER, Janelle F et al.The American journal of cardiology. 2007, Vol 100, Num 3, pp 554-555, issn 0002-9149, 2 p.Article

Justification for the use of statins in primary prevention : An intervention trial evaluating rosuvastatin (JUPITER)- Can C-reactive protein be used to target statin therapy in primary prevention?MORA, Samia; RIDKER, Paul M.The American journal of cardiology. 2006, Vol 97, Num 2A, issn 0002-9149, 33A-41A, SUPConference Paper

Short-Term Rosuvastatin Therapy for Prevention of Contrast-Induced Acute Kidney Injury in Patients With Diabetes and Chronic Kidney DiseaseYALING HAN; GUOYING ZHU; SHIFANG DING et al.Journal of the American College of Cardiology. 2014, Vol 63, Num 1, pp 62-70, issn 0735-1097, 9 p.Article

Short-time pretreatment of rosuvastatin attenuates myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein expressionBING WU; ZHIJUN SU; RONG LIN et al.International journal of cardiology. 2013, Vol 168, Num 5, pp 4946-4948, issn 0167-5273, 3 p.Article

Rosuvastatin calcium in acute coronary syndromesAGGARWAL, Rajesh K; SHOWKATHALI, Refai.Expert opinion on pharmacotherapy. 2013, Vol 14, Num 9, pp 1215-1227, issn 1465-6566, 13 p.Article

Statins and daptomycin: safety assessment of concurrent use and evaluation of drug interaction liabilityGOLIGHTLY, Larry K; BARBER, Gerard R; BARRON, Michelle A et al.Drug metabolism and drug interactions. 2013, Vol 28, Num 1, pp 49-58, issn 0792-5077, 10 p.Article

Achievement of LDL-C goals depends on baseline LDL-C and choice and dose of statin: An analysis from the VOYAGER databasePALMER, Mike K; NICHOLLS, Stephen J; LUNDMAN, Pia et al.European journal of preventive cardiology (Print). 2013, Vol 20, Num 6, pp 1080-1087, issn 2047-4873, 8 p.Article